Pharmacokinetic Interaction of Finasteride With Tamsulosin Hydrochloride: An Open-label, Randomized, 3-period Crossover Study in Healthy Chinese Male Volunteers
- 20 November 2014
- journal article
- research article
- Published by Elsevier in Clinical Therapeutics
- Vol. 37 (2) , 462-472
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: A randomized placebo controlled trialInternational Journal of Urology, 2014
- Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosinBritish Journal of Clinical Pharmacology, 2011
- The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT StudyJournal of Urology, 2008
- Combination Therapy With Doxazosin and Finasteride for Benign Prostatic Hyperplasia in Patients With Lower Urinary Tract Symptoms and a Baseline Total Prostate Volume of 25 Ml or GreaterJournal of Urology, 2006
- A comparison of two phase III multicenter, placebo-controlled studies of tamsulosin in BPHAdvances in Therapy, 2000
- Phase III Multicenter Placebo-Controlled Study of Tamsulosin in Benign Prostatic HyperplasiaUrology, 1998
- A dose‐ranging study of the efficacy and safety of tamsulosin, the first prostate‐selective &agr; 1A ‐adrenoceptor antagonist*, in patients with benign prostatic obstructionBritish Journal of Urology, 1997